Published in OncoTargets and Therapy · View the paper (DOI)
Researchers developed a blood test that analyzes circulating tumor DNA to predict treatment response in metastatic HPV-positive throat cancer. The test showed promise in identifying non-responding patients months earlier than standard imaging scans.
Coverage from 2 institutions